![Aura Biosciences Inc](/common/images/company/N_AURA.png)
Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to...
BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to...
Continued Enrollment in Global Phase 3 CoMpass Trial in Small Choroidal Melanoma and Indeterminate Lesions Ongoing Phase 1 Trial in Bladder Cancer Enrolling; Early Data Expected Mid-2024 Strong...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.52 | 17.1945701357 | 8.84 | 10.93 | 8.495 | 139216 | 9.47306052 | CS |
4 | 2.79 | 36.856010568 | 7.57 | 10.93 | 6.8 | 148173 | 8.46783422 | CS |
12 | 2.35 | 29.3383270911 | 8.01 | 10.93 | 6.63 | 159647 | 7.65234126 | CS |
26 | 2.73 | 35.7798165138 | 7.63 | 10.93 | 6.63 | 168922 | 7.74717486 | CS |
52 | -0.99 | -8.72246696035 | 11.35 | 12.44 | 5.99 | 155523 | 8.08220063 | CS |
156 | -3.74 | -26.524822695 | 14.1 | 26.16 | 5.99 | 115471 | 11.01430113 | CS |
260 | -3.74 | -26.524822695 | 14.1 | 26.16 | 5.99 | 115471 | 11.01430113 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.